Published in J Comput Aided Mol Des on August 24, 2013
Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening. Wiley Interdiscip Rev Comput Mol Sci (2015) 0.81
Towards predictive docking at aminergic G-protein coupled receptors. J Mol Model (2015) 0.79
The Augmenting Effects of Desolvation and Conformational Energy Terms on the Predictions of Docking Programs against mPGES-1. PLoS One (2015) 0.76
Synthesis and receptor binding in trans-CD ring-fused A-CD estrogens: comparison with the cis-fused isomers. Bioorg Med Chem Lett (2014) 0.75
A critical assessment of docking programs and scoring functions. J Med Chem (2006) 5.78
A new method for predicting binding affinity in computer-aided drug design. Protein Eng (1994) 3.79
Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities. J Comput Aided Mol Des (1996) 3.78
Calculations of antibody-antigen interactions: microscopic and semi-microscopic evaluation of the free energies of binding of phosphorylcholine analogs to McPC603. Protein Eng (1992) 2.15
Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. Br J Pharmacol (2007) 2.13
Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem (1999) 2.11
Protonate3D: assignment of ionization states and hydrogen coordinates to macromolecular structures. Proteins (2009) 1.81
Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 2. Computational titration and pH effects in molecular models of neuraminidase-inhibitor complexes. J Med Chem (2003) 1.56
A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking. Bioinformatics (2010) 1.48
Consensus scoring criteria for improving enrichment in virtual screening. J Chem Inf Model (2005) 1.41
Scoring functions for protein-ligand docking. Curr Protein Pept Sci (2006) 1.29
Flexible alignment of small molecules. J Med Chem (2001) 1.22
NNScore: a neural-network-based scoring function for the characterization of protein-ligand complexes. J Chem Inf Model (2010) 1.21
Can the calculation of ligand binding free energies be improved with continuum solvent electrostatics and an ideal-gas entropy correction? J Comput Chem (2002) 1.21
An iterative knowledge-based scoring function to predict protein-ligand interactions: I. Derivation of interaction potentials. J Comput Chem (2006) 1.19
Limits of Free Energy Computation for Protein-Ligand Interactions. J Chem Theory Comput (2010) 1.18
NNScore 2.0: a neural-network receptor-ligand scoring function. J Chem Inf Model (2011) 1.12
Improved ligand-protein binding affinity predictions using multiple binding modes. Biophys J (2010) 1.04
A machine learning-based method to improve docking scoring functions and its application to drug repurposing. J Chem Inf Model (2011) 1.03
Quantitative binding site model generation: compass applied to multiple chemotypes targeting the 5-HT1A receptor. J Med Chem (1995) 1.01
Docking ligands into flexible and solvated macromolecules. 4. Are popular scoring functions accurate for this class of proteins? J Chem Inf Model (2009) 0.99
Estimation of binding free energies for HIV proteinase inhibitors by molecular dynamics simulations. Protein Eng (1995) 0.98
Predicting protein-ligand binding affinities using novel geometrical descriptors and machine-learning methods. J Chem Inf Comput Sci (2004) 0.94
Identification of a minimal subset of receptor conformations for improved multiple conformation docking and two-step scoring. J Chem Inf Comput Sci (2004) 0.93
Docking ligands into flexible and solvated macromolecules. 3. Impact of input ligand conformation, protein flexibility, and water molecules on the accuracy of docking programs. J Chem Inf Model (2009) 0.89
A-CD estrogens. I. Substituent effects, hormone potency, and receptor subtype selectivity in a new family of flexible estrogenic compounds. J Med Chem (2010) 0.84
Deconstructing estradiol: removal of B-ring generates compounds which are potent and subtype-selective estrogen receptor agonists. Bioorg Med Chem Lett (2008) 0.83
AutoShim: empirically corrected scoring functions for quantitative docking with a crystal structure and IC50 training data. J Chem Inf Model (2008) 0.81
Training a scoring function for the alignment of small molecules. J Chem Inf Model (2010) 0.80
Docking ligands into flexible and solvated macromolecules. 5. Force-field-based prediction of binding affinities of ligands to proteins. J Chem Inf Model (2009) 0.77
Surrogate AutoShim: predocking into a universal ensemble kinase receptor for three dimensional activity prediction, very quickly, without a crystal structure. J Chem Inf Model (2008) 0.76
Claudins and epithelial paracellular transport. Annu Rev Physiol (2006) 4.79
An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell (2011) 4.04
First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med (2012) 3.56
The projected timing of climate departure from recent variability. Nature (2013) 3.00
NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nat Chem Biol (2008) 2.44
Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. Hum Mol Genet (2003) 2.36
The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci (2008) 2.36
Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol (2003) 2.31
Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol (2005) 2.30
Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials (2003) 2.27
Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol (2003) 2.17
International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev (2006) 2.15
ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell (2009) 2.10
Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol (2008) 2.09
Tricellulin is a tight-junction protein necessary for hearing. Am J Hum Genet (2006) 2.05
Zonula occludens-1 and -2 are cytosolic scaffolds that regulate the assembly of cellular junctions. Ann N Y Acad Sci (2009) 1.96
Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. J Biol Chem (2006) 1.91
Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest (2010) 1.90
Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns (2006) 1.86
Intestinal malrotation in children: a problem-solving approach to the upper gastrointestinal series. Radiographics (2006) 1.85
Two splice variants of claudin-10 in the kidney create paracellular pores with different ion selectivities. Am J Physiol Renal Physiol (2006) 1.84
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol (2002) 1.83
Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. Endocrinology (2002) 1.74
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer. Breast Cancer Res Treat (2008) 1.72
Antagonists selective for estrogen receptor alpha. Endocrinology (2002) 1.70
Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am J Pathol (2002) 1.70
Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Mol Endocrinol (2008) 1.70
Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem (2004) 1.67
Zonula occludens-1 and -2 regulate apical cell structure and the zonula adherens cytoskeleton in polarized epithelia. Mol Biol Cell (2011) 1.60
Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate. Mol Endocrinol (2002) 1.53
Biomedicine. Defining the "S" in SERMs. Science (2002) 1.52
Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur J Nucl Med Mol Imaging (2005) 1.52
Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding. J Med Chem (2004) 1.50
The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction. J Biomed Mater Res A (2010) 1.48
Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A (2007) 1.47
Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. Mol Endocrinol (2006) 1.43
Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity. J Med Chem (2004) 1.43
Maternal circulating endothelial progenitor cells in normal singleton and twin pregnancy. Am J Obstet Gynecol (2008) 1.42
In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J Biomed Mater Res A (2003) 1.42
The unique-5 and -6 motifs of ZO-1 regulate tight junction strand localization and scaffolding properties. Mol Biol Cell (2006) 1.40
Structure of the conserved cytoplasmic C-terminal domain of occludin: identification of the ZO-1 binding surface. J Mol Biol (2005) 1.39
Estrogen receptor β ligands: recent advances and biomedical applications. Med Res Rev (2011) 1.38
Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab (2004) 1.37
Palmitoylation of claudins is required for efficient tight-junction localization. J Cell Sci (2005) 1.36
Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proc Natl Acad Sci U S A (2002) 1.34
Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection. Mol Endocrinol (2009) 1.34
Characterization of topographical effects on macrophage behavior in a foreign body response model. Biomaterials (2010) 1.33
The attrition of young physician-scientists: problems and potential solutions. Gastroenterology (2007) 1.32
Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J Biol Chem (2007) 1.32
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands. Chem Biol (2007) 1.31
Giant cell formation and function. Curr Opin Hematol (2009) 1.30
Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. Am J Physiol Gastrointest Liver Physiol (2007) 1.29
Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc Natl Acad Sci U S A (2010) 1.28
Net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion. J Am Soc Nephrol (2011) 1.28
Occludin is required for cytokine-induced regulation of tight junction barriers. J Cell Sci (2010) 1.26
Coupling of receptor conformation and ligand orientation determine graded activity. Nat Chem Biol (2010) 1.25
Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs). Mol Endocrinol (2009) 1.25
Dimerization of the scaffolding protein ZO-1 through the second PDZ domain. J Biol Chem (2006) 1.24
Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors. Mol Cell (2004) 1.24
Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci U S A (2013) 1.21
Indazole estrogens: highly selective ligands for the estrogen receptor beta. J Med Chem (2005) 1.21
Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interaction. ACS Chem Biol (2008) 1.21
Development of novel antioxidants: design, synthesis, and reactivity. J Org Chem (2003) 1.20
Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding. J Med Chem (2008) 1.19
Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials. J Biomed Mater Res A (2008) 1.18
Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants. Cell Microbiol (2007) 1.17
Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation. Mol Endocrinol (2005) 1.17
Hormone-PAMAM dendrimer conjugates: polymer dynamics and tether structure affect ligand access to receptors. Angew Chem Int Ed Engl (2006) 1.16
Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities. J Biol Chem (2011) 1.15
Oxidative mechanisms of poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo and in vitro correlations. J Biomed Mater Res A (2004) 1.15
Alternative inhibition of androgen receptor signaling: peptidomimetic pyrimidines as direct androgen receptor/coactivator disruptors. ACS Chem Biol (2009) 1.13
The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J Neurochem (2008) 1.13
Claudin-2 forms homodimers and is a component of a high molecular weight protein complex. J Biol Chem (2010) 1.10
Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. J Biomed Mater Res A (2009) 1.10
Lymphocytes and the foreign body response: lymphocyte enhancement of macrophage adhesion and fusion. J Biomed Mater Res A (2005) 1.10
c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells. Cancer Res (2013) 1.09
Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. J Biomed Mater Res A (2008) 1.09
Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. J Biomater Sci Polym Ed (2004) 1.09
Macrophage fusion and multinucleated giant cells of inflammation. Adv Exp Med Biol (2011) 1.09
Tricellulin deficiency affects tight junction architecture and cochlear hair cells. J Clin Invest (2013) 1.09
Multinucleated giant cell formation exhibits features of phagocytosis with participation of the endoplasmic reticulum. Exp Mol Pathol (2005) 1.08
Directed evolution of specific receptor-ligand pairs for use in the creation of gene switches. Proc Natl Acad Sci U S A (2005) 1.08
Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor. J Med Chem (2003) 1.07
A proteomic microarray approach for exploring ligand-initiated nuclear hormone receptor pharmacology, receptor selectivity, and heterodimer functionality. Mol Cell Proteomics (2004) 1.07
Epithelial barrier assembly requires coordinated activity of multiple domains of the tight junction protein ZO-1. J Cell Sci (2013) 1.07
Phytochemistry and antifungal properties of the newly discovered tree Pleodendron costaricense. J Nat Prod (2006) 1.07
A set of time-resolved fluorescence resonance energy transfer assays for the discovery of inhibitors of estrogen receptor-coactivator binding. J Biomol Screen (2009) 1.05
Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods. J Biomed Mater Res A (2007) 1.05
Molecular sensors of estrogen receptor conformations and dynamics. Mol Endocrinol (2003) 1.04
alpha subunit partners to beta1 and beta2 integrins during IL-4-induced foreign body giant cell formation. J Biomed Mater Res A (2007) 1.04
The role of claudins in determining paracellular charge selectivity. Proc Am Thorac Soc (2004) 1.04
Student Research Award in the Undergraduate Degree Candidate category, 30th Annual Meeting of the Society for Biomaterials, Memphis, Tennessee, April 27-30, 2005. Monocyte/lymphocyte interactions and the foreign body response: in vitro effects of biomaterial surface chemistry. J Biomed Mater Res A (2005) 1.03
The Src homology 3 domain is required for junctional adhesion molecule binding to the third PDZ domain of the scaffolding protein ZO-1. J Biol Chem (2011) 1.03
Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production. J Biomed Mater Res A (2008) 1.03
Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators. Mol Syst Biol (2013) 1.03
Domain swapping within PDZ2 is responsible for dimerization of ZO proteins. J Biol Chem (2007) 1.02
Phosphorylation of claudin-2 on serine 208 promotes membrane retention and reduces trafficking to lysosomes. J Cell Sci (2012) 1.02
Bicyclo[2.2.2]octanes: close structural mimics of the nuclear receptor-binding motif of steroid receptor coactivators. Bioorg Med Chem Lett (2007) 1.01
Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains. J Med Chem (2007) 1.01
Maternal arterial stiffness in pregnancies affected by preeclampsia. Am J Physiol Heart Circ Physiol (2009) 1.00